BDNF and depressive symptom measurement: Another interesting finding in this study was that the development of depression-like phenotypes after prenatal exposure to a supra-therapeutic dose of buprenorphine was accompanied by decreased circulating levels of BDNF and serotonin, TrkB phosphorylation, and CREB activity.